What is the appropriate workup for a 17-year-old patient with hypoglycemia (low blood sugar)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For a 17-year-old with hypoglycemia, the initial workup should prioritize identifying the underlying cause of hypoglycemia, and management should focus on preventing recurrent episodes and improving quality of life, as recommended by the latest standards of care in diabetes-2023 1. The initial evaluation should include a comprehensive history, physical examination, and laboratory testing during a hypoglycemic episode, with a focus on measuring glucose, insulin, C-peptide, proinsulin, beta-hydroxybutyrate, and sulfonylurea levels when blood glucose is below 70 mg/dL. Some key points to consider in the workup and management include:

  • Identifying the underlying cause of hypoglycemia, such as insulinoma, insulin autoimmune syndrome, factitious hypoglycemia, or inborn errors of metabolism
  • Immediate treatment of hypoglycemic episodes with 15-20g of fast-acting carbohydrates, such as glucose tablets or juice, followed by complex carbohydrates, as recommended by the standards of care in diabetes-2023 1
  • For recurrent episodes, frequent small meals high in complex carbohydrates and protein may help maintain glucose levels
  • Patients should carry glucose tablets and glucagon emergency kits, and wear medical alert identification, as glucagon should be prescribed for all individuals at increased risk of level 2 or 3 hypoglycemia 1
  • Endocrinology referral is essential for specialized testing and treatment planning, as some causes like insulinoma may require surgical intervention while others may need specific medication regimens or dietary modifications. The goal of management should be to prevent recurrent hypoglycemic episodes, improve quality of life, and reduce the risk of long-term complications, as emphasized by the latest guidelines 1.

From the FDA Drug Label

The recommended dosage is 1 mg (1 mL) injected subcutaneously or intramuscularly into the upper arm, thigh, or buttocks, or intravenously Adults and Pediatric Patients Weighing More Than 25 kg or for Pediatric Patients with Unknown Weight 6 Years and Older

For a 17-year-old patient with hypoglycemia, the recommended dosage of glucagon is 1 mg (1 mL) injected subcutaneously or intramuscularly into the upper arm, thigh, or buttocks, or intravenously 2.

From the Research

Hypoglycemia Workup for a 17-year-old

  • Hypoglycemia is a common condition in patients with type 1 diabetes and type 2 diabetes, and it can be a major limiting factor in achieving glycaemic control 3
  • The American Diabetes Association Standards of Medical Care recommends that a management protocol for hypoglycaemia should be designed and implemented by every hospital, along with a clear prevention and treatment plan 3
  • Increased hypoglycaemia risk is observed with the use of insulin and/or sulphonylureas, and vulnerable patients with type 2 diabetes at dual risk of severe hypoglycaemia and cardiovascular outcomes may be better treated with GLP-1 receptor agonists or SGLT2 inhibitors rather than insulin 3

Diagnostic Considerations

  • Continuous glucose monitoring (CGM) should be considered for all individuals with increased risk for hypoglycaemia, impaired hypoglycaemia awareness, frequent nocturnal hypoglycaemia, and with a history of severe hypoglycaemia 3
  • Patients with impaired awareness of hypoglycaemia may benefit from real-time CGM 3
  • Octreotide, a somatostatin analogue, may be effective in treating hypoglycaemia in patients with insulinoma, but it can also worsen existing hypoglycemia by suppressing glucagon and growth hormone 4, 5, 6

Treatment Options

  • Optimizing insulin doses and carbohydrate intake, in addition to a short warm-up before or after physical activity sessions, may help avoid hypoglycaemia 3
  • Octreotide may be a useful addition or alternative to diazoxide in controlling symptoms of congenital hyperinsulinism, and it may also be useful in the management of hypoglycemic symptoms in adult patients requiring medical treatment for insulinoma who are refractory or intolerant of diazoxide 6
  • The efficacy of octreotide treatment on hypoglycaemia in patients with insulinoma is related to the presence of tumoral somatostatin receptors sst2A and sst5, and positive anti-sst2 receptor immunostaining is associated with efficacy of octreotide treatment 5

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Research

Hypoglycaemia and its management in primary care setting.

Diabetes/metabolism research and reviews, 2020

6
Research

Octreotide in hyperinsulinism.

The Annals of pharmacotherapy, 1997

Related Questions

What is the indication for Octreotide (Somatostatin analogue) in the treatment of hypoglycemia?
In an 86-year-old male diabetic patient on glyburide (Glibenclamide), metformin, and Farxiga (Dapagliflozin) with hypoglycemia, which medication should be adjusted first?
What is the best initial treatment approach for a pediatric patient presenting with hyperglycemia, tachycardia, elevated liver enzymes, and elevated uric acid levels?
What insulin adjustment is recommended for a diabetes patient experiencing hypoglycemia (low blood sugar) with noon glucose levels around 2 mmol/L, currently taking 5 units of short-acting insulin (regular insulin) with breakfast, 7 units with lunch, and 7 units with supper?
What is the appropriate management for a 65-year-old female with a history of fall due to hypoglycemia, currently presenting with hyperglycemia, and taking metformin (Metformin hydrochloride) 1000 milligrams (mg) twice daily?
What is the first diagnostic step for a 32-year-old man with a recent diagnosis of Hepatitis C Virus (HCV) infection, presenting with progressive fatigue and edema of the lower extremities, to determine the extent of fibrosis?
Which medication should be discontinued in a patient with impaired renal function, taking losartan (angiotensin II receptor antagonist) and amlodipine (calcium channel blocker) for hypertension, omeprazole (proton pump inhibitor) for gastroesophageal reflux disease, naproxen (nonsteroidal anti-inflammatory drug) for knee osteoarthritis, and atorvastatin (HMG-CoA reductase inhibitor) for hyperlipidemia, presenting with pyuria and leukocyturia?
Is Ultratherapy (ultrasound therapy) effective for skin care?
What oral antifungal medications can be given without checking liver enzymes (liver function tests)?
What is the most appropriate additional treatment for a 52-year-old woman with hypertension, currently on Losartan (angiotensin II receptor antagonist) and Chlorthalidone (thiazide-like diuretic), with a blood pressure of 145/82 mmHg, normokalemia (serum potassium level of 3.6 mEq/L), and normal renal function (serum creatinine level of 0.8 mg/dL)?
What are the recommendations for follow-up in a patient with pulmonary hypertension (PH)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question